Project title
開發新穎藥物克服肺腺癌EGFRC797S突變導致EGFR-TKI之抗藥性 (II)
Internal ID
MOST106-2314-B002-103-MY2
Principal Investigator
Start Date
August 1, 2018
End Date
July 12, 2019
Partner Organizations
Discovery of the Novel Compounds to Overcome Egfr C797s Mediated Tki Resistance in Lung Adenocarcinoma (II) = 開發新穎藥物克服肺腺癌EGFRC797S突變導致EGFR-TKI之抗藥性 (II)
Keywords
表皮生長因子受體(EGFR)
突變
抗藥性
C797S 點突變
EGFR
HTS
C797S
EGFR-TKI
HTS